Menopause-related Vasomotor Symptoms
📧 Sign up to get email alerts when something new happens for Menopause-related Vasomotor Symptoms.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-10-26Clinical Trial Update: FP-101 Versus Placebo in the Treatment of Menopausal Vasomotor Symptoms [Phase 2]
Phase 2 trial update evaluating FP-101 vs placebo for vasomotor symptoms associated with menopause has completed.
-
CLINICAL_TRIALS trial_result · 2021-08-05Clinical Trial Update: Post Marketing Surveillance To Observe Safety And Efficacy Of Duavive
Post-marketing surveillance trial to observe safety and efficacy of Duavive in severe vasomotor symptoms of menopause has completed with res…
-
CLINICAL_TRIALS trial_result · 2013-12-11Clinical Trial Update: Dehydroepiandrosterone (DHEA) + Acolbifene Against Vasomotor Symptoms (Hot Flushes) in Postmenopausal Women [Phase 3]
Phase 3 trial evaluating dehydroepiandrosterone (DHEA) plus acolbifene for vasomotor symptoms (hot flashes) in postmenopausal women has comp…
-
CLINICAL_TRIALS trial_result · 2012-03-26Clinical Trial Update: A Study to Evaluate the Effects of RAD1901 in the Treatment of Vasomotor Symptoms in Postmenopausal Women [Phase 2]
A Phase 2 trial evaluating RAD1901 for vasomotor symptoms (hot flashes) in postmenopausal women has completed with results posted in 2012.
-
CLINICAL_TRIALS trial_result · 2011-06-08Clinical Trial Update: Study of Gabapentin Extended Release (G-ER) in the Treatment of Vasomotor (Hot Flashes/Hot Flushes) Symptoms in Postmenopausal Women [Phase 2]
Phase 2 study of gabapentin extended-release for vasomotor symptoms in postmenopausal women has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.